| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Net sales | $4.75B+9.7% | $4.33B+7.4% | $4.04B |
| Cost of sales | $2.56B+9.4% | $2.34B+2.6% | $2.28B |
| Research and development expenses | $354.0M+12.7% | $314.0M+3.6% | $303.0M |
| Selling, general and administrative expenses | $620.0M+2.8% | $603.0M+13.1% | $533.0M |
| Amortization of intangibles | $207.0M-10.8% | $232.0M-11.5% | $262.0M |
| Restructuring and asset related charges - net | $20.0M+150.0% | $8.0M-84.6% | $52.0M |
| Acquisition, integration and separation costs | $25.0M | $0 | $0 |
| Equity in earnings of nonconsolidated affiliates | $47.0M+27.0% | $37.0M+131.3% | $16.0M |
| Interest expense | $65.0M | $0 | $0 |
| Other income (expense) - net | $11.0M-56.0% | $25.0M+127.3% | $11.0M |
| Income before income taxes | $962.0M+6.8% | $901.0M+42.6% | $632.0M |
| Provision for income taxes | $233.0M+31.6% | $177.0M+78.8% | $99.0M |
| Net income | $729.0M+0.7% | $724.0M+35.8% | $533.0M |
| Net income attributable to noncontrolling interests | $37.0M+19.4% | $31.0M+19.2% | $26.0M |
| Net income available for Qnity common stockholders | $692.0M-0.1% | $693.0M+36.7% | $507.0M |
| Earnings per common share - basic (in USD per share) | $3300000.00-0.3% | $3310000.00+36.8% | $2420000.00 |
| Earnings per common share - diluted (in USD per share) | $3300000.00-0.3% | $3310000.00+36.8% | $2420000.00 |
| Weighted-average common shares outstanding - basic (in shares) | 209.6M+0.1% | 209.4M+0.0% | 209.4M |
| Weighted-average common shares outstanding - diluted (in shares) | 209.8M+0.2% | 209.4M+0.0% | 209.4M |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.